Ken Fisher
KNSA icon

Ken Fisher’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Ken Fisher’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.7M Buy
428,972
+161,698
+60% +$7.16M 0.01% 326
2025
Q4 		$11M Sell
267,274
-15,014
-5% -$602K ﹤0.01% 390
2025
Q3 		$11M Buy
282,288
+180,029
+176% +$5.85M ﹤0.01% 393
2025
Q2 		$2.83M Sell
102,259
-41,992
-29% -$1.07M ﹤0.01% 542
2025
Q1 		$3.2M Buy
144,251
+118,127
+452% +$2.43M ﹤0.01% 526
2024
Q4 		$517K Hold
26,124
– – ﹤0.01% 770
2024
Q3 		$653K Sell
26,124
-4,101
-14% -$99.9K ﹤0.01% 718
2024
Q2 		$564K Buy
+30,225
New +$566K ﹤0.01% 767

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Ken Fisher's KNSA Position: Q1 2026 in Review

Ken Fisher increased its Kiniksa Pharmaceuticals (KNSA) stake by 60% in Q1 2026, buying an estimated $7.16M and bringing the position to 428,972 shares worth $20.7M. The position accounts for 0.01% of the portfolio, ranked #326.

Ken Fisher first reported a position in KNSA in Q2 2024 and has held it in 8 quarters since. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Ken Fisher held 428,972 shares of Kiniksa Pharmaceuticals worth $20.7M as of Q1 2026.
  • Ken Fisher bought 161,698 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $7.16M.
  • Kiniksa Pharmaceuticals made up 0.01% of Ken Fisher's portfolio in Q1 2026, its #326 holding.
  • Ken Fisher first reported a position in Kiniksa Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.